#biotherapeutics

📰

First Tracks: Huge Cash Reserves Will Not Sustain Testing For Long

Seeking Alpha·Cypriot Invests·27 days ago

#source #chevron #alpha #seeking #tracks #investment

First Tracks Biotherapeutics, spun off from AnaptysBio, launches with $180M cash and a diverse, early-stage pipeline. Read why I rate TRAX stock a Hold now.

15s

Menu

First Tracks: Huge Cash Reserves Will Not Sustain Testing For Long